| | Author, year | Sample size | Interventions | Control | Treatment course | Outcome | | TCM | CG |
| | Zhu Hong, 2020 | 43 | 42 | Shenling Baizhu granule + a | a | 2 weeks | ①④ | | Yao Na, 2019 | 42 | 42 | Shenling Baizhu granule + a | a | 5 days | ①②⑤⑥ | | Wang Fuhai, 2020 | 38 | 38 | Shenling Baizhu granule + a | a | 5 days | ②③④⑤⑦⑧ | | Luo Linlin, 2014 | 60 | 60 | Shenling Baizhu granule + a | a | 5 days | ①②⑥ | | Shou-Xin Wang, 2020 | 60 | 60 | Xingpi Yanger granule + a | a | 7 days | ①②⑤⑪ | | Tian Tian, 2018 | 85 | 80 | Xingpi Yanger granule + a | a | 5-7 days | ①②③⑧⑫⑬ | | Huijuan Qi, 2020 | 42 | 42 | Xingpi Yanger granule + a | a | 5 days | ①⑤⑨⑪⑫ | | LinJian Ying, 2019 | 53 | 53 | Xingpi Yanger granule + a | a | 3 days | ① | | Rong Li, 2020 | 25 | 25 | Xingpi Yanger granule + a | a | 3∼5 days | ①②⑫⑬ | | Liu Huijin, 2017 | 48 | 48 | Xingpi Yanger granule + a | a | 7 days | ①②⑧ | | Zhang Minzhen, 2018 | 39 | 39 | Jianpi Bushen decoction + a | a | 7 days | ①②③ | | Fan Zhang, 2021 | 49 | 41 | Erxieting granules + a | a | 72 h | ①②③⑤⑨ | | Cao fang, 2016 | 100 | 60 | Erxieting granules + a | a | 72 h | ① | | Yuan Chaogang, 2022 | 60 | 60 | Huangqi Jianzhong decoction + a | a | 6 days | ①②⑤ | | Yang Liping, 2016 | 50 | 50 | Weichangan pill + a | a | 7 days | ①②③⑮ | | Guo Xinning, 2016 | 58 | 50 | Weichangan pill + a | a | 7 days | ①② | | Ma Jingyan, 2017 | 51 | 52 | Weichangan pill + a | a | 7 days | ① | | Chun-Ling Yang, 2017 | 35 | 35 | Jianpi Bushen decoction + a | a | 72 h | ①② | | Yong-jun xu, 2015 | 84 | 58 | Sijunzi decoction + a | a | 5–10 days | ①② | | Tu Xufei, 2020 | 54 | 54 | Modified Yigong powder + a | a | 7 days | ①⑤③ | | RuanXiaoDong, 2019 | 57 | 57 | Xiaoer Fuxie powder + a | a | 2 weeks | ①②⑬⑨⑩ | | Bai jin, 2017 | 56 | 56 | Xiaoer Fuxie powder + a | a | 2 weeks | ①②⑬⑨⑩ | | Li-fang cao, 2017 | 43 | 43 | Yiersan + a | a | 5 days | ① | | Ma Xiaopeng, 2016 | 60 | 60 | Guben Yichang tablets + a | a | 2 weeks | ①②④⑦⑬⑨ | | Fan Jiayu, 2021 | 25 | 25 | Buzhong Yiqi particles+ a | a | 1 week | ① | | Li-fang cao, 2015 | 45 | 44 | Qiweibaizhu powder+a | a | 10 days | ① |
|
|
a: conventional therapy: antidiarrheal, fluid, diet adjustment, correct electrolyte imbalance, probiotics, montmorillonite powder, and so on; CG: control group. ①total effective rate; ②Antidiarrheal time; ③Diarrhea frequency; ④T cell subset: CD3+, CD4 +, CD8 +, CD4 +/CD8 +; ⑤The time to change the shape of feces; ⑥Time for bowel sounds to return to normal; ⑦Immune indice: CD3+, CD4+, IgA, IgG, IgM; ⑧intestinal barrier function: bacterial endotoxin(BT), diamine oxidase(DAO), D-Lactic acid(D-LC); ⑨Vomiting improvement time; ⑩Inflammatory factors: hs-CRP, IL8, IL-12, and TNF-α; ⑪Gastrointestinal hormones: gastrin(GAS), motilin(MOT), somatostatin(SS); ⑫Average hospital stay; ⑬Normal temperature time.
|
